Contraceptive Pills and Retinal Vascularization

Fondation Ophtalmologique Adolphe de Rothschild51 enrolled

Overview

The main hypothesis is the taking of combined 1st and 2nd generation or 3rd and 4th generation oral contraceptives is associated with a change in retinal micro-vascularization compared to the absence of combined oral contraceptive intake. Women of childbearing age will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to their medical and ophthalmologic history and their oestro-progestative contraceptive intake will be collected. The objective is to find an association between retinal vascular density and combined oral contraceptives intake.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Combined Oral Contraceptives Intake

Interventions

OCT-A (optical coherence tomography)DIAGNOSTIC_TEST

Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.

Eligibility

Medical Language ↔ Plain English

Inclusion criteria * for the control group : No Estro-progestin contraceptive treatment (oral, transdermal) for at least 6 months * for the cases under combined 1st and 2nd generation pills : Estro-progestin contraceptive treatment for at least 6 months * for the cases under combined 3rd and 2th generation pills: Estro-progestin contraceptive treatment for at least 6 months Exclusion criteria: * Menopausal woman * Ametropia greater than + 3 hyperopia diopters or-3 myopia diopters * Astigmatism greater than 2 dioptres * Smoking patient (cigarette or e-cigarette) * Caffeine intake within 2 hours prior to the OCT-A exam * Any known retinal pathology * Antecedent of deep vein thrombosis or deep arterial thrombosis

Contraceptive Pills and Retinal Vascularization

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes